The Industry Roundtable brings together researchers from academic medical health centers, industry partners, and advocacy organizations to discuss and advance non-proprietary issues relating to drug and device development, evaluative and comparative effectiveness research, and the dissemination of knowledge about clinical research findings. The purpose is to provide a forum to collaboratively identify, clarify and solve common challenges related to clinical research, as well as to foster a broader, consistent relationship and understanding where academia and industry interface.
Registration Fee for CR Forum Members: $0.00
Registration Fee for non-CR Forum Members: $500
Panel # 1: 21st Century Cures Act - What's Next?
Congress passed the 21st Century Cures Act to accelerate the rate at which scientific breakthroughs are translated into treatments, therapies, and products that improve patient care. Now that the bill has been enacted, learn what’s happening with implementation and the Administration’s plans to further bolster clinical and translational research.
Panel #2: Future Challenges for Industry-Funded Research
The federal government has indicated an interest in improving public/private partnerships as well as increasing the role of user fees in regulatory review. Hear from leading members of industry about what’s next in terms of future collaboration and partnerships critical to research projects and opportunities.
8/8/2017CCTS Newsletter | August 4, 2017
8/2/2017Industry Roundtable Seeks to Accelerate Clinical Research to Clinical Care
7/25/2017 CCTS Newsletter | July 25, 2017
7/11/2017CCTS Newsletter | July 7, 2017
11/2/2017 » 11/3/2017IT Roundtable
2025 M Street NW, Suite 800 Washington DC 20036
Tel: 202.367.1176 | Fax: 202.367.2176